Novel ultrahigh resolution microCT imaging system
Novel ultrahigh resolution microCT imaging system
批准号:
7794779
负责人:
Daniel S Perrien
金额:
$46.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2011-08-31
关键词:
AffectAnimalsArchitectureAreaBiliaryBlood capillariesBone callusBone neoplasmsCaliberCollaborationsComputersData SetDevelopmentDiseaseDuct (organ) structureEnsureFosteringFractureFundingFutureHepatic TissueHousingImageInstitutesInstitutionInvestigationMalignant NeoplasmsMalignant neoplasm of prostateMultiple MyelomaMusPilot ProjectsPorosityResearchResearch PersonnelResolutionScienceSpatial DistributionSpecimenSpeedStructureSupport SystemSystemTimeUnited StatesUnited States National Institutes of HealthUniversitiesX-Ray Computed Tomographyangiogenesisbonebone qualitycapillarycapillary bedcraniofacialdata acquisitionimaging modalityimprovedinstrumentmalignant breast neoplasmmineralizationnovelpublic health relevancescaffoldskeletalsubmicrontissue culturetissue regeneration
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The purpose of this application is to purchase a novel, ultrahigh resolution micro computed tomography system for non-destructive three dimensional analyses of synthetic and ex vivo specimens. The proposed Scanco 5CT50 system is the first and only system currently capable of producing images with submicron voxels in a field of view large enough for small animal specimens. If successful, Vanderbilt will be the first academic institution in the United States to obtain a system with these capabilities. This system will open new avenues of research because it will resolve heretofore hidden features such as porosity in murine cortical bone, the spatial distribution of mineralization in trabeculae, the complete structure of capillary beds and biliary vasculature. Moreover, its speed and automated specimen loading system will reduce data acquisition time and investigator wait time. Thus, the 5CT50 will support and expand numerous, wide ranging, NIH funded projects as well as pilot projects for future investigations. Supported projects include investigations on angiogenesis, skeletal consequences of breast cancer, prostate cancer, and multiple myeloma, bone quality, craniofacial development, endochondral ossification, biliary duct development, and development of tissue culture scaffolds. Aspects of each of these studies are focused on microstructures (e.g., the tumor- bone interface, mineralizing fracture callus, microcracks, biliary ducts, capillaries, etc.) that are often 5¿- 5mm in size and will therefore be significantly enhanced by the superior resolution of the 5CT50. In addition, these projects will benefit from the increased access and speed of the improved computer support system. This system will reconstruct and analyze data sets that significantly exceed the capabilities of other currently available systems. Due to its ground breaking resolution, the 5CT50 will undoubtedly foster collaborations within Vanderbilt University and at neighboring institutions. Housing this instrument in the Vanderbilt University Institute for Imaging Science (VUIIS), which has been highly successful in managing numerous, imaging modalities for users, will ensure campus wide access and superior management. Acquisition of the 5CT50 will hasten important discoveries and treatments in areas of craniofacial, cancer, skeletal, hepatic and tissue regeneration fields, among others.
PUBLIC HEALTH RELEVANCE: This novel microCT, which is not currently housed by any U.S. company or institution, is the only instrument available that can acquire images of small animal specimens with detail to see structures as small as 1 micrometer in diameter. This instrument will allow investigators to obtain heretofore unattainable information about the three dimensional architecture of microstructures that affect disease and development.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Methods for the reliable induction of heterotopic ossification in the conditional Alk2Q207D mouse.
在有条件的 Alk2Q207D 小鼠中可靠诱导异位骨化的方法。
DOI:
--
发表时间:
2020
期刊:
Journal of musculoskeletal & neuronal interactions
影响因子:
1.9
作者:
[Pan,Haichun, Fleming,Nicole, Hong,CharlesC, Mishina,Yuji, Perrien,DanielS]
通讯作者:
Perrien,DanielS
DOI:
10.1002/jbmr.2316
发表时间:
2015-01
期刊:
JOURNAL OF BONE AND MINERAL RESEARCH
影响因子:
6.2
作者:
[Ndong, Jean de la Croix, Stevens, David M., Vignaux, Guillaume, Uppuganti, Sasidhar, Perrien, Daniel S., Yang, Xiangli, Nyman, Jeffry S., Harth, Eva, Elefteriou, Florent]
通讯作者:
Elefteriou, Florent
DOI:
10.1089/ten.tea.2015.0355
发表时间:
2016-02
期刊:
Tissue engineering. Part A
影响因子:
--
作者:
[A. D. Talley;Kerem N. Kalpakci;Daniel A. Shimko;Katarzyna J. Zienkiewicz;D. Cochran;S. Guelcher]
通讯作者:
A. D. Talley;Kerem N. Kalpakci;Daniel A. Shimko;Katarzyna J. Zienkiewicz;D. Cochran;S. Guelcher
DOI:
10.1002/jbm.b.33349
发表时间:
2015-11
期刊:
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
影响因子:
3.4
作者:
[Prieto, Edna M., Talley, Anne D., Gould, Nicholas R., Zienkiewicz, Katarzyna J., Drapeau, Susan J., Kalpakci, Kerem N., Guelcher, Scott A.]
通讯作者:
Guelcher, Scott A.
DOI:
10.1038/nm.3583
发表时间:
2014-08
期刊:
Nature medicine
影响因子:
82.9
作者:
[]
通讯作者:
共 7 条
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10434101
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10249238
-
项目类别:
-
资助金额:$42.39万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10150273
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10168215
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10407678
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
The contribution of innate immunity to heterotopic ossification in fibrodysplasia ossificans progressiva
-
批准号:10616939
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2019
-
负责人:Daniel S Perrien
-
依托单位:
Immune cells and cytokines mediating fibrodysplasia ossificans progressiva
-
批准号:8871583
-
项目类别:
-
资助金额:$20.72万
-
财政年份:2015
-
负责人:Daniel S Perrien
-
依托单位:
vivaCT80 - in vivo small animal microCT
-
批准号:8639867
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2014
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8667309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8774183
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
Interventions and Mechanisms of Disuse Osteopenia
-
批准号:8442139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Daniel S Perrien
-
依托单位:
海外基金